Navigation Links
Cell Transplants Hold Promise for Heart Attack Survivors
Date:12/6/2007

Studies in mice suggest they might prevent cardiac arrest

THURSDAY, Dec. 6 (HealthDay News) -- Researchers say they're moving closer to using transplanted cells to protect heart attack survivors from suffering sudden cardiac arrest.

Working with mice, scientists strengthened the heart's electrical system to prevent it from going haywire. "We're showing that the electrical risk can be reversed," said study co-author Dr. Michael Kotlikoff, a professor in the department of biomedical sciences at Cornell University.

It's still unclear, however, how long it may take before the research could be tested in humans.

At stake is the health of people who survive heart attacks. They face a higher risk of another life-threatening event known as cardiac arrest, which occurs when the electrical system in the heart loses its ability to properly control heartbeat.

The heart "goes into an irregular rhythm, stops functioning and stops pumping blood at all," Kotlikoff said.

The higher risk may have something to do with disruption in cells around areas of the heart that were damaged during a heart attack, said Dr. Kenneth Chien, director of the Massachusetts General Hospital Cardiovascular Research Center in Boston. He was not involved in the research.

According to the new study, previous transplantation of cells into human heart-attack survivors has had mixed results. So, Kotlikoff and colleagues from Germany and the United States tried a new approach by transplanting genetically engineered embryonic heart cells into the hearts of mice after they had heart attacks.

According to Kotlikoff, the cells become mature heart cells and produce a molecule that helps electrical impulses move between cells.

The new findings, which are published in the Dec. 6 issue of Nature, have now outlined the "mechanism underlying the reversal" of the risk of irregular heartbeat after a heart attack, Kotlikoff said.

Cell transplantation "increases the electrical conduction within the damaged or dead section of (heart) tissue," he said.

According to Kotlikoff, the next steps are to figure out whether the cells could provide protection in people and for how long.

Potentially, the cells could be delivered to the heart -- perhaps through a tube -- and prevent heart-attack survivors from having to get pacemakers, Kotlikoff said.

Chien called the study findings "a step in the right direction," but said the method's blend of gene and cell-based therapy could be troublesome. Federal regulators "are very stringent about gene therapy, let alone gene and cell therapy (together)," he said.

More information

There's more on cardiac arrest and heart attack at the American Heart Association.



SOURCES: Michael Kotlikoff, V.M.D., Ph.D., Austin O. Hooey Dean, professor, Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, N.Y.; Kenneth Chien, M.D., director, Massachusetts General Hospital Cardiovascular Research Center, Boston; Dec. 6, 2007, Nature


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families
2. New Heart Pump Helps Women Awaiting Transplants
3. Blood-incompatible infant heart transplants safe, may save more lives
4. Blood-Incompatible Heart Transplants Safe for Infants
5. Lung Transplants May Not Help Most Cystic Fibrosis Children
6. Alcohol may amplify chronic rejection in lung transplants
7. Bone marrow cell transplants help nerve regeneration
8. New study shows promise in reducing surgical risks associated with surgical bleeding
9. New Heart Pump Shows Promise in Trial
10. Blood-flow detector software show promise in preventing brain damage
11. New type of drug shows promise in attacking melanoma in an innovative way
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell Transplants Hold Promise for Heart Attack Survivors
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: